Cellectar Biosciences, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Cellectar Biosciences, Inc. (CLRB) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.02% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-03-04
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was -0.02%, a 104.55% decline from fiscal 2024.
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.44%, a 214.29% increase from fiscal 2023.
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was 0.14%.
- Cellectar Biosciences, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.29%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -0.02% 10-K · filed 2026-03-04 | |
| 2024-12-31 | 0.44% 10-K · filed 2026-03-04 | 0.45% 10-K · filed 2025-03-13 |
| 2023-12-31 | 0.14% 10-K · filed 2025-03-13 | -0.32% 10-K · filed 2024-03-27 |
| 2022-12-31 | -0.29% 10-K/A · filed 2024-10-29 | -0.31% 10-K · filed 2023-03-09 |
| 2021-12-31 | -1.13% 10-K · filed 2023-03-09 | 1.13% 10-K · filed 2022-03-21 |
| 2020-12-31 | -10.26% 10-K · filed 2022-03-21 | -0.26% 10-K · filed 2021-03-02 |
| 2019-12-31 | 1.85% 10-K · filed 2021-03-02 | |
| 2018-12-31 | 1.50% 10-K · filed 2020-03-09 | |
| 2017-12-31 | -1.80% 10-K · filed 2019-02-26 | |
| 2016-12-31 | 3.61% 10-K · filed 2018-03-21 | |
| 2015-12-31 | -0.92% 10-K · filed 2017-03-15 | |
| 2014-12-31 | 1.01% 10-K/A · filed 2016-10-20 | 0.99% 10-K · filed 2015-03-24 |
| 2013-12-31 | 4.12% 10-K · filed 2015-05-20 | |
| 2012-12-31 | -6.02% 10-K · filed 2014-03-19 | |
| 2011-12-31 | -15.35% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |